WallStreetZen

NASDAQ: GEVO
Gevo Inc Stock Forecast, Predictions & Price Target

Analyst price target for GEVO

Based on 2 analysts offering 12 month price targets for Gevo Inc.
Min Forecast
$10.00+51.75%
Avg Forecast
$14.00+112.44%
Max Forecast
$18.00+173.14%

Should I buy or sell GEVO stock?

Based on 2 analysts offering ratings for Gevo Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

GEVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Stifel Nicolaus
Top 50%
51
Strong BuyInitiates Coverage On$10.00+51.75%2021-08-24
HC Wainwright & Co.
Top 8%
93
BuyMaintains$18.00+173.14%2021-02-19

1 of 1

Forecast return on equity

Is GEVO forecast to generate an efficient return?
Company
8.9%
Industry
35%
Market
2,530.69%
GEVO's Return on Equity is forecast to be low in 3 years (8.9%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is GEVO forecast to generate an efficient return on assets?
Company
7.48%
Industry
9.86%
Market
1,237.47%
GEVO is forecast to generate lower Return on Assets (7.48%) than the US Specialty Chemicals industry average (9.86%)
Forecast

GEVO earnings per share forecast

What is GEVO's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.29-9.38%
Avg 2 year Forecast
-$0.26-18.75%
Avg 3 year Forecast
-$0.18-43.75%

GEVO revenue forecast

What is GEVO's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.3M+7.11%
Avg 2 year Forecast
$4.4M+252.18%
Avg 3 year Forecast
$15.3M+1,137.88%
GEVO's revenue is forecast to grow at an exceptional rate of 124.06% per year
Forecast

GEVO revenue growth forecast

How is GEVO forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
124.06%
Industry
6.7%
Market
12.38%
GEVO's revenues are forecast to grow faster (124.06% per year) than the US Specialty Chemicals industry average (6.7%)
Forecast
GEVO's revenues are forecast to grow faster (124.06% per year) than the US market average (12.38%)
Forecast

Gevo Stock Forecast FAQ

Is Gevo Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GEVO) stock is to Strong Buy GEVO stock.

Out of 2 analysts, 1 (50%) are recommending GEVO as a Strong Buy, 1 (50%) are recommending GEVO as a Buy, 0 (0%) are recommending GEVO as a Hold, 0 (0%) are recommending GEVO as a Sell, and 0 (0%) are recommending GEVO as a Strong Sell.

What is GEVO's earnings growth forecast for 2021-2023?

(NASDAQ: GEVO) Gevo's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 23.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.62%.

Gevo's earnings in 2021 is -$53,200,000.On average, 3 Wall Street analysts forecast GEVO's earnings for 2021 to be $-57,192,230, with the lowest GEVO earnings forecast at $-61,136,522, and the highest GEVO earnings forecast at $-51,275,792. On average, 2 Wall Street analysts forecast GEVO's earnings for 2022 to be $-51,275,792, with the lowest GEVO earnings forecast at $-59,164,376, and the highest GEVO earnings forecast at $-43,387,209.

In 2023, GEVO is forecast to generate $-35,498,625 in earnings, with the lowest earnings forecast at $-39,442,917 and the highest earnings forecast at $-31,554,334.

What is GEVO's revenue growth forecast for 2021-2023?

(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 124.06% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 6.7%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 12.38%.

Gevo's revenue in 2021 is $1,238,000.On average, 3 Wall Street analysts forecast GEVO's revenue for 2021 to be $261,506,541, with the lowest GEVO revenue forecast at $197,214,586, and the highest GEVO revenue forecast at $347,097,671. On average, 2 Wall Street analysts forecast GEVO's revenue for 2022 to be $859,855,595, with the lowest GEVO revenue forecast at $536,423,674, and the highest GEVO revenue forecast at $1,183,287,516.

In 2023, GEVO is forecast to generate $3,022,313,530 in revenue, with the lowest revenue forecast at $1,311,476,997 and the highest revenue forecast at $4,733,150,064.

What is GEVO's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: GEVO) forecast ROA is 7.48%, which is lower than the forecast US Specialty Chemicals industry average of 9.86%.

What is GEVO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GEVO price target, the average GEVO price target is $14.00, with the highest GEVO stock price forecast at $18.00 and the lowest GEVO stock price forecast at $10.00.

On average, Wall Street analysts predict that Gevo's share price could stay at $14.00 by Aug 24, 2022. The average Gevo stock price prediction forecasts a potential downside of N/A from the current GEVO share price of $6.59.

What is GEVO's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: GEVO) Gevo's current Earnings Per Share (EPS) is -$0.32. On average, analysts forecast that GEVO's EPS will be $-0.29 for 2021, with the lowest EPS forecast at $-0.31, and the highest EPS forecast at $-0.26. On average, analysts forecast that GEVO's EPS will be $-0.26 for 2022, with the lowest EPS forecast at $-0.30, and the highest EPS forecast at $-0.22. In 2023, GEVO's EPS is forecast to hit $-0.18 (min: $-0.20, max: $-0.16).

What is GEVO's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: GEVO) forecast ROE is 8.9%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.